Veeva Systems stock

VEEV · NYSE · USD

Compare Veeva Systems
$301.53Change from previous close: −0.29%Absolute change: −$0.89

Close · November 13, 2026

Price history

+3.37% over the period

1 year: from $291.70 (November 13, 2025) to $301.53 (November 13, 2026), +3.37%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 13, 2026$301.53
October 30, 2026$312.96
September 30, 2026$285.45
August 31, 2026$285.69
July 31, 2026$203.78
June 30, 2026$177.47
May 29, 2026$174.34
April 30, 2026$155.97
March 31, 2026$175.66
February 27, 2026$182.01
January 30, 2026$203.92
December 31, 2025$223.23
November 28, 2025$240.29
November 13, 2025$291.70

At a glance

  • The company

    Provides cloud-based software for life sciences including CRM, clinical trial management, regulatory information, and quality management solutions

  • Latest results

    Quarter to July 31, 2026 · EPS $2.35 (estimate $2.22)

TickerLandia's take on Veeva Systems

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk low$148.05
52-wk high$325.99

−7.50% from the 52-week high

Analysts · 29 analysts

Average target$326.41+8.25% vs. price

Buy 20 · Hold 8 · Sell 1 · Buy

TickerLandia Fingerprint: Veeva Systems

Compared with similar companies: very high financial strength, very high price, and very high profitability.

Financials and price compared with 44 companies in related industries (health_services), worldwide. Momentum and risk compared with 883 North American stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Veeva Systems is cheaper than in the past and in line with similar companies

On the latest fiscal year's earnings (2026), Veeva Systems's P/E today is 55.4, below the median of its last 10 fiscal years (69.3; between 37.5 and 117.1 from 2017 to 2026). Veeva Systems's Forward P/E: 29.4, in line with the median of a group of 5 similar companies (29.4).

P/E compared with its history

Compared with 5 similar companies

Veeva Systems's metrics compared with similar companies
MetricVeeva SystemsPosition in the groupBand
Forward P/E29.4Middle
Operating margin29.9%High
ROE14.4%High
Debt/equity0.02Middle
Price/book6.57Middle

P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Veeva Systems. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

$927.96M

Latest quarter · Q to Jul 2026

Net income

$273.43M

Latest quarter · Q to Jul 2026

Quarterly net margin

29.5%

Latest quarter · Q to Jul 2026

Numbers and valuation

Full valuation
Market cap
$48.82B
P/E
49.4
EPS
$6.10
Volume
737.3K
Daily trading
€388.17M
Dividend yield
0.00%

How Veeva Systems is changing

All results
  • Revenue grew 16.9% a year on average over the last 5 years

  • Operating margin rose from 21.3% to 28.7%

  • Profits turn into cash: free cash flow equal to 155% of net income

Returns

Veeva Systems returns

$1,000 invested in Veeva Systems 5 years ago, on November 15, 2021, would be worth $956 today: −4.44% in total, −0.91% per year. This is the price return only: dividends are excluded.

PeriodVeeva SystemsS&P 500$1,000 becomes
1 month−0.03%−3.12%$1,000
6 months+93.62%+1.58%$1,936
Year to date+35.08%+10.46%$1,351
1 year+3.37%+12.23%$1,034
3 years+81.37%+71.41%$1,814
5 years−4.44%+61.48%$956
10 years+655.71%+249.40%$7,557

Over the last 6 months it has done better than 97% of the stocks in the Healthcare sector.

Price only, without dividends. Calculate your investment

The chart in detail

Veeva Systems: technical analysis

Veeva Systems is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 11.6% below its all-time closing high ($341.00, August 5, 2021).

Trend
Upward
RSI (14 sessions)
49
Between 30 and 70
vs 200-session average
+41.21%

Active signals

  • The price is moving in an unusually narrow range compared with the last year.

    since November 5, 2026

Support and resistance

Price areas where Veeva Systems has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last price$301.53
  3. Support$294.21−2.43%3 touches, last on November 6, 2026
  4. Support$246.03−18.41%2 touches, last on January 9, 2026
  5. Support$236.71−21.50%2 touches, last on August 26, 2026

Volatility and risk

Over the last year it has moved less than the S&P 500.

Beta (1 year) vs S&P 500
0.52
Volatility (60 sessions, annualised)
40.6%
Largest fall in the last year
−48.38%

Close of November 13, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Veeva Systems: seasonality

Average monthly price change over 13 years

+3.5%Jan+2.1%Feb+0.1%Mar−1.1%Apr+7.2%May+6.8%Jun+4.6%Jul+7.9%Aug−3.6%Sep+0.2%Oct+3.4%Nov−8.1%Dec

Over the last 13 years, the strongest month for Veeva Systems has been August: +7.95% on average, positive in 7 years out of 13. The weakest has been December: −8.05% on average, positive in 1 years out of 13. November, the current month, has been positive in 9 years out of 13 (+3.39% on average).

Show chart data
MonthAverageMedianPositive years
January+3.49%+4.23%9 of 13
February+2.12%+1.33%8 of 13
March+0.07%+3.09%8 of 13
April−1.13%+0.89%7 of 13
May+7.18%+10.31%10 of 13
June+6.81%+5.03%11 of 13
July+4.62%+4.00%9 of 13
August+7.95%+2.19%7 of 13
September−3.56%−3.04%3 of 13
October+0.20%−0.50%6 of 13
November+3.39%+5.18%9 of 13
December−8.05%−7.72%1 of 13

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Veeva Systems and its competitors

With 7,928 employees, the company builds cloud software for pharmaceutical, biotechnology and other life sciences firms. Its applications cover commercial operations, from CRM and promotional content management to medical content and customer data, as well as clinical trial execution, drug safety, regulatory information management and quality systems. Services include implementation, data migration, systems integration, training and outsourced administration. Its customers include pharmaceutical and biotechnology companies as well as other life sciences firms.

Headquarters
Pleasanton, United States
Employees
7,928
Founded
2007
Chief executive
Peter Gassner
Veeva Systems and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Veeva SystemsVEEV$48.82B29.9%49.4+93.62%
Tempus AITEM$13.06B-18.5%—+55.99%
DoximityDOCS$5.95B27.1%46.3+42.54%
Pro MedicusPME$14.57B74.9%81.4+65.15%
M32413$7.61B19.5%26.5+34.35%
XtalPi Holdings2228$3B-124.6%—−32.46%

Same industry or related industries, similar size. Compare Veeva Systems with its competitors · Full profile